Clinical features and prognostic factors affecting survival of ambulatory followed COVID-19 patients aged over 65 years

Basit Öğe Kaydı
dc.authoridYalçınsoy, Murat/0000-0003-3407-7359
dc.authoridTaş, Ayşe/0000-0001-9909-4411
dc.authoridKasapoglu, Umut Sabri/0000-0003-2869-9872
dc.authorwosidYalçınsoy, Murat/ABI-1421-2020
dc.authorwosidTaş, Ayşe/Y-1075-2018
dc.authorwosidKasapoglu, Umut Sabri/F-1786-2019
dc.contributor.authorYalcinsoy, Murat
dc.contributor.authorSelcuk, Engin Burak
dc.contributor.authorUckac, Kadir
dc.contributor.authorSahin, Abdullah Fahri
dc.contributor.authorTas, Ayse
dc.contributor.authorKasapoglu, Umut
dc.contributor.authorBentli, Recep
dc.date.accessioned2024-08-04T20:57:26Z
dc.date.available2024-08-04T20:57:26Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: The majority of the patients with COVID-19 are followed ambulatory. Determination of prognostic factors of mortality in risky groups is essential to improve patient management. The aim of this study is to describe the clinical presentation in patients over 65 years of age with COVID-19 who are followed up at home by a physician and provide insights into the initial prognostic factors in this distinctive population. Material and Methods: This is a retrospective and observational study. Clinical records of the patients aged over 65 years who were visited by the filiation team, including a physician at home, due to the diagnosis of COVID-19 disease within 2 months were reviewed. Factors affecting mortality were examined. Results: Our study included 51 deceased (mean age: 75,1 +/- 9,0 years, 40,2% males), and 102 patients with COVID-19 who survived (mean age: 73,0 +/- 6,9 years, 68,6% male). Platelet count ( < 150.000, OR 7,26, p=0,001), CRP level ( < 4, OR 4,55, p=0,02), albumin level ( OR 3,24, p=0,02), and Troponin I level (OR 0,03, p=0,02) were the strongest predictors for death. When propensity score matching was applied, gender (male, OR 7,14, p=0,02) and platelet count (< 150.000, OR 5,34, p=0,02) were the strongest predictor Discussion: Elderly COVID-19 patients have a high mortality rate. An easily measurable and accessible platelet count may be a predictor of a bad outcome. Close follow-up and timely treatment may significantly reduce mortality in high- risk elderly patients under.en_US
dc.identifier.doi10.4328/ACAM.21083
dc.identifier.endpage668en_US
dc.identifier.issn2667-663X
dc.identifier.issue6en_US
dc.identifier.startpage663en_US
dc.identifier.urihttps://doi.org/10.4328/ACAM.21083
dc.identifier.urihttps://hdl.handle.net/11616/102604
dc.identifier.volume13en_US
dc.identifier.wosWOS:001027513600016en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBayrakol Medical Publisheren_US
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectFrail Elderlyen_US
dc.subjectAmbulatory Careen_US
dc.subjectMortalityen_US
dc.titleClinical features and prognostic factors affecting survival of ambulatory followed COVID-19 patients aged over 65 yearsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu